Adma Biologics (ADMA) Net Cash Flow (QoQ) (2011 - 2025)
Adma Biologics (ADMA) Net Cash Flow (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 190.81% |
| Sep 30, 2025 | -254.88% |
| Jun 30, 2025 | 159.20% |
| Mar 31, 2025 | -291.74% |
| Dec 31, 2024 | 1,169.62% |
| Sep 30, 2024 | -103.58% |
| Jun 30, 2024 | 812.11% |
| Mar 31, 2024 | 73.57% |
| Dec 31, 2023 | -295.85% |
| Sep 30, 2023 | 274.02% |
| Jun 30, 2023 | 61.36% |
| Mar 31, 2023 | -133.55% |
| Dec 31, 2022 | 394.80% |
| Sep 30, 2022 | -2.45% |
| Jun 30, 2022 | -192.80% |
| Mar 31, 2022 | 10.42% |
| Dec 31, 2021 | 308.52% |
| Sep 30, 2021 | 59.10% |
| Jun 30, 2021 | -423.54% |
| Mar 31, 2021 | 261.02% |